Welcome to our dedicated page for Aemetis SEC filings (Ticker: AMTX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Aemetis, Inc. filings document the renewable fuels company's operating results, governance, capital structure, and material agreements tied to its renewable natural gas, ethanol, and biodiesel businesses.
Recent Form 8-K reports furnish quarterly and annual earnings releases, Regulation FD materials, changes in the independent registered public accounting firm, amendments to the Delaware certificate of incorporation, stockholder voting results, financing-related agreements at Aemetis Biogas, and related-party guarantee-fee and executive compensation arrangements. Proxy materials cover board matters, executive pay, equity awards, annual meeting matters, and voting procedures for AMTX common stock listed on the Nasdaq Global Market.
Aemetis, Inc. director Simon Timothy Alan sold shares in the company. He completed an open-market sale of 10,000 shares of Common Stock at a weighted average price of about $2.05 per share. After this transaction, he directly holds 42,632 shares of Aemetis Common Stock.
The reported sale price reflects a weighted average of multiple trades within a range of $2.04 to $2.06 per share, as noted in the footnote. The filing does not show any related option exercises or derivative positions, indicating this was a straightforward common stock sale.
AMTX reported a proposed sale of Common Stock via Form 144. The notice lists transactions tied to RSU vesting events dated 06/10/2026, with reported lots of 6,441, 10,000 and 2,559 shares and a broker identified as Raymond James & Associates. The filing indicates cash sale of vested common shares on 06/10/2026.
Aemetis, Inc. held its Annual Meeting of Stockholders on May 20, 2026. Stockholders voted on the election of one director and the ratification of the company’s independent auditor.
For the board election, Lydia I. Beebe received 18,110,640 votes for, 627,847 withheld, and 19,501,347 broker non-votes. She was elected as a Class II director to serve until the 2029 annual meeting and until a successor is elected and qualified.
Stockholders also voted on the ratification of the company’s independent registered public accounting firm. KPMG LLP received 37,777,860 votes for, 85,378 against, and 376,596 abstentions, with no broker non-votes, and was ratified as auditor for the fiscal year ending December 31, 2026.
Aemetis, Inc. reported first‑quarter 2026 revenue of $54.6 million, up from $42.9 million, driven by strong growth in India biodiesel and California renewable natural gas plus new Section 45Z production tax credits.
Gross profit improved to $2.8 million from a $5.1 million loss, but the company still posted a net loss of $21.7 million and used $10.6 million of cash in operating activities. Total debt reached $404.7 million, with $342.6 million classified as current and several facilities due on demand. Management discloses substantial doubt about the company’s ability to continue as a going concern absent refinancing, additional financing, and continued cooperation from its senior lender.
Aemetis, Inc. reported first quarter 2026 results showing strong top-line growth but continued losses. Revenue rose 27% year over year to $54.6 million, driven by contributions from California Ethanol, Dairy Renewable Natural Gas (RNG), and India Biodiesel.
The company generated $2.8 million of gross profit, reversing a gross loss in the prior-year quarter, helped by Section 45Z Production Tax Credits and improved Dairy RNG performance. Operating loss narrowed to $6.3 million, and net loss improved to $21.7 million, while Adjusted EBITDA improved to negative $1.3 million from negative $10.7 million.
Dairy RNG volumes increased 55% to 110,000 MMBtu, and India Biodiesel revenue reached $10.5 million with resumed tender orders. The company ended the quarter with $4.8 million in cash and continues to invest in low-carbon projects and multi-track financing initiatives, including work toward an IPO of its India subsidiary.
Aemetis, Inc. is calling its 2026 Annual Meeting of Stockholders for May 20, 2026 in Palo Alto. Stockholders of record at the close of business on March 26, 2026, when 68,145,588 common shares were outstanding, may vote.
Investors will vote on electing Lydia I. Beebe to a new three-year term as a Class II director through 2029 and on ratifying KPMG LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, replacing RSM US LLP. The proxy also outlines board structure, director and executive pay, equity plans, severance protections, and related-party employment of family members of the CEO.
Waltz Todd reported acquisition or exercise transactions in this Form 4 filing.
Aemetis, Inc. Executive Vice President and CFO Todd Waltz received a compensation grant of options to buy 200,000 shares of common stock at $2.64 per share. These options begin vesting after the grant date, with 1/12 of the option shares vesting every three months.
The options are exercisable until March 19, 2036 and relate to 200,000 underlying shares of common stock. Following this award, the filing shows Waltz holding a total of 1,305,701 derivative securities, indicating a sizeable ongoing equity-based stake aligned with company performance.
Aemetis Executive Vice President Sanjeev Gupta received a stock option grant covering 200,000 shares of Common Stock. The option has an exercise price of $2.64 per share, was granted on March 19, 2026, and expires on March 19, 2036. This is a compensation-related award rather than an open-market purchase. Following this grant, Gupta holds options on 1,385,000 shares as reported. According to the vesting terms, one‑twelfth of the option shares vest every three months from the grant date.
ROCKETT JAMES MICHAEL reported acquisition or exercise transactions in this Form 4 filing.
Aemetis, Inc. executive vice president and general counsel James Michael Rockett received a grant of stock options, giving him the right to buy 200,000 shares of common stock at $2.64 per share. Following this award, he holds options covering 700,000 shares in total.
The options begin vesting over time. According to the terms, 1/12 of the option shares vest every three months from the grant date of this award, creating a four-year vesting schedule that ties the value of the grant to continued service and the company’s longer-term performance.
BLOCK JOHN R reported acquisition or exercise transactions in this Form 4 filing.
Aemetis, Inc. director John R. Block received a grant of 10,000 shares of Common Stock at $2.64 per share. The award was issued as compensation for his service on the Board of Directors under the Aemetis, Inc. Amended and Restated 2019 Stock Plan. Following this grant, he holds 56,330 shares of Aemetis Common Stock directly.